Advertisement

Molecular Medicine

, Volume 20, Issue 1, pp 10–16 | Cite as

Resveratrol Restores Sirtuin 1 (SIRT1) Activity and Pyruvate Dehydrogenase Kinase 1 (PDK1) Expression after Hemorrhagic Injury in a Rat Model

  • Bixi Jian
  • Shaolong Yang
  • Irshad H. Chaudry
  • Raghavan Raju
Research Article

Abstract

Severe hemorrhage leads to decreased blood flow to tissues resulting in decreased oxygen and nutrient availability affecting mitochondrial function. A mitoscriptome profiling study demonstrated alteration in several genes related to mitochondria, consistent with the mitochondrial functional decline observed after trauma hemorrhage (T-H). Our experiments led to the identification of sirtuin 1 (SIRT1) as a potential target in T-H. Administration of resveratrol (a naturally occurring polyphenol and activator of SIRT1) after T-H improved left ventricular function and tissue ATP levels. Our hypothesis was that mitochondrial function after T-H depends on SIRT1 activity. In this study, we evaluated the activity of SIRT1, a mitochondrial functional modulator, and the mitochondrial-glycolytic balance after T-H. We determined the changes in protein levels of pyruvate dehydrogenase kinase (PDK)-1 and nuclear c-Myc, peroxisome proliferator-activated receptor-γ coactivator (PGC)-1α and NF-E2-related factor (NRF)2 after T-H and after treatment with resveratrol or a combination of sirtinol (a SIRT1 inhibitor) and resveratrol. We have also tested the activity of mitochondrial complex 1. SIRT1 enzyme activity was significantly decreased after T-H, whereas resveratrol treatment restored the activity. We found elevated PDK1 and c-Myc levels and decreased PGC-1α, NRF2 and mitochondrial complex I activity after T-H. The reduced SIRT1 activity after T-H may be related to declining mitochondrial function, since resveratrol was able to reinstate SIRT1 activity and mitochondrial function. The elevated level of PDK1 (an inhibitor of pyruvate dehydrogenase complex) after T-H indicates a possible shift in cellular energetics from mitochondria to glycolysis. In conclusion, SIRT1 modulation alters left ventricular function after T-H through regulation of cellular energetics.

Notes

Acknowledgments

The authors acknowledge the support of National Institutes of Health Grants GM101927 (to R Raju) and GM 39519 (to IH Chaudry).

References

  1. 1.
    Curry N, et al. (2011) The acute management of trauma hemorrhage: a systematic review of randomized controlled trials. Crit. Care. 15: R92.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Geeraedts LM Jr, Kaasjager HA, van Vugt AB, Frolke JP. (2009) Exsanguination in trauma: A review of diagnostics and treatment options. Injury. 40:11–20.CrossRefPubMedGoogle Scholar
  3. 3.
    Ba ZF, et al. (2000) Alterations in tissue oxygen consumption and extraction after trauma and hemorrhagic shock. Crit. Care Med. 28:2837–42.CrossRefPubMedGoogle Scholar
  4. 4.
    Hsieh CH, et al. (2009) Trauma-hemorrhage and hypoxia differentially influence kupffer cell phagocytic capacity: role of hypoxia-inducible-factor-1alpha and phosphoinositide 3-kinase/Akt activation. Ann. Surg. 250:995–1001.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Jian B, Yang S, Chaudry I, Raju R. (2012) Resveratrol improves cardiac contractility following trauma-hemorrhage by modulating Sirt1. Mol. Med. 18:209–14.CrossRefPubMedGoogle Scholar
  6. 6.
    Rixen D, Siegel JH. (2005) Bench-to-bedside review: oxygen debt and its metabolic correlates as quantifiers of the severity of hemorrhagic and post-traumatic shock. Crit. Care. 9:441–53.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Raju R, Bland KI, Chaudry IH. (2008) Estrogen: a novel therapeutic adjunct for the treatment of trauma-hemorrhage-induced immunological alterations. Mol. Med. 14:213–21.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Raju R, Chaudry IH. (2008) Sex steroids/receptor antagonist: their use as adjuncts after trauma-hemorrhage for improving immune/cardiovascular responses and for decreasing mortality from subsequent sepsis. Anesth. Analg. 107:159–66.CrossRefPubMedGoogle Scholar
  9. 9.
    Meldrum DR, et al. (1997) Hemorrhage activates myocardial NFkappaB and increases TNF-alpha in the heart. J. Mol. Cell. Cardiol. 29:2849–54.CrossRefPubMedGoogle Scholar
  10. 10.
    Chima RS, et al. (2011) C-peptide ameliorates kidney injury following hemorrhagic shock. Shock. 35:524–9.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Hsieh YC, et al. (2006) Inhibition of cardiac PGC-1alpha expression abolishes ERbeta agonist-mediated cardioprotection following trauma-hemorrhage. FASEB J. 20:1109–17.CrossRefPubMedGoogle Scholar
  12. 12.
    Fulda S, Debatin KM. (2007) HIF-1-regulated glucose metabolism: a key to apoptosis resistance? Cell Cycle. 6:790–2.CrossRefPubMedGoogle Scholar
  13. 13.
    Smith RA, Hartley RC, Cocheme HM, Murphy MP. (2012) Mitochondrial pharmacology. Trends Pharmacol. Sci. 33:341–52.CrossRefPubMedGoogle Scholar
  14. 14.
    Chen Q, Lesnefsky EJ. (2006) Depletion of cardiolipin and cytochrome c during ischemia increases hydrogen peroxide production from the electron transport chain. Free Radic. Biol. Med. 40:976–82.CrossRefPubMedGoogle Scholar
  15. 15.
    Childs EW, et al. (2002) In vivo visualization of reactive oxidants and leukocyte-endothelial adherence following hemorrhagic shock. Shock. 18:423–7.CrossRefPubMedGoogle Scholar
  16. 16.
    Semenza GL. (2012) Hypoxia-inducible factors in physiology and medicine. Cell. 148:399–408.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Jian B, et al. (2010) Hypoxia induced alteration of mitochondrial genes in cardiomyocytes: role of Bnip3 and Pdk1. Shock. 34:169–75.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Kim JW, Tchernyshyov I, Semenza GL, Dang CV. (2006) HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 3:177–85.CrossRefPubMedGoogle Scholar
  19. 19.
    Jian B, et al. (2011) Aging influences cardiac mitochondrial gene expression and cardiovascular function following hemorrhage injury. Mol. Med. 17:542–9.CrossRefPubMedGoogle Scholar
  20. 20.
    Jian B, Yang S, Chen Q, Chaudry I, Raju R. (2011) Influence of aging and hemorrhage injury on Sirt1 expression: possible role of myc-Sirt1 regulation in mitochondrial function. Biochim. Biophys. Acta. Mol. Basis Dis. 1812:1446–51.CrossRefGoogle Scholar
  21. 21.
    Michan S, Sinclair D. (2007) Sirtuins in mammals: insights into their biological function. Biochem. J. 404:1–13.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Imai S, Guarente L. (2010) Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases. Trends Pharmacol. Sci. 31:212–20.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Brunet A, et al. (2004) Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science. 303:2011–5.CrossRefPubMedGoogle Scholar
  24. 24.
    Fusco S, Maulucci G, Pani G. (2012) Sirt1: defeating senescence? Cell Cycle. 11:4135–46.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Raju R, Jian B, Hubbard W, Chaudry I. (2011) The mitoscriptome in aging and disease. Aging Dis. 2:174–80.PubMedPubMedCentralGoogle Scholar
  26. 26.
    Lu A, et al. (2007) Mitochondria play an important role in 17beta-estradiol attenuation of H(2)O(2)-induced rat endothelial cell apoptosis. Am. J. Physiol. Endocrinol. Metab. 292:E585–93.CrossRefPubMedGoogle Scholar
  27. 27.
    Chaudry IH. (1983) Cellular mechanisms in shock and ischemia and their correction. Am. J. Physiol. 245:R117–34.PubMedGoogle Scholar
  28. 28.
    Chaudry IH, Ohkawa M, Clemens MG. (1984) Improved mitochondrial function following ischemia and reflow by ATP-MgCl2. Am. J. Physiol. 246:R799–804.PubMedGoogle Scholar
  29. 29.
    Hsieh YC, et al. (2006) Upregulation of mitochondrial respiratory complex IV by estrogen receptor-beta is critical for inhibiting mitochondrial apoptotic signaling and restoring cardiac functions following trauma-hemorrhage. J. Mol. Cell. Cardiol. 41:511–21.CrossRefPubMedGoogle Scholar
  30. 30.
    Lu A, et al. (2007) Mitochondria play an important role in 17beta-estradiol attenuation of H(2)O(2)-induced rat endothelial cell apoptosis. Am. J. Physiol. Endocrinol. Metab. 292:E585–93.CrossRefPubMedGoogle Scholar
  31. 31.
    Galley HF. (2011) Oxidative stress and mitochondrial dysfunction in sepsis. Br. J. Anaesth. 107:57–64.CrossRefPubMedGoogle Scholar
  32. 32.
    Lowes DA, Webster NR, Murphy MP, Galley HF. (2013) Antioxidants that protect mitochondria reduce interleukin-6 and oxidative stress, improve mitochondrial function, and reduce biochemical markers of organ dysfunction in a rat model of acute sepsis. Br. J. Anaesth. 110:472–80.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Chung S, et al. (2010) Regulation of SIRT1 in cellular functions: role of polyphenols. Arch Biochem Biophys. 501:79–90.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Baur JA, et al. (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 444:337–42.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Gilde AJ, et al. (2003) Peroxisome proliferator-activated receptor (PPAR) alpha and PPAR-beta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism. Circ. Res. 92:518–24.CrossRefPubMedGoogle Scholar
  36. 36.
    Duncan JG. (2011) Peroxisome proliferator activated receptor-alpha (PPARalpha) and PPAR gamma coactivator-1alpha (PGC-1alpha) regulation of cardiac metabolism in diabetes. Pediatr. Cardiol. 32:323–8.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Chorley BN, et al. (2012) Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha. Nucleic Acids Res. 40:7416–29.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Joshi G, Johnson JA. (2012) The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases. Recent Pat. CNS Drug Discov. 7:218–29.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Kaplon J, et al. (2013) A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence. Nature. 498:109–12.CrossRefPubMedGoogle Scholar
  40. 40.
    Buler M, Aatsinki SM, Skoumal R, Hakkola J. (2011) Energy sensing factors PGC-1alpha and SIRT1 modulate PXR expression and function. Biochem. Pharmacol. 82:2008–15.CrossRefPubMedGoogle Scholar
  41. 41.
    Jian B, et al. (2009) Anosmin-1 involved in neuronal migration is hypoxia inducible and cancer regulated. Cell Cycle. 8:3770–6.CrossRefPubMedGoogle Scholar

Copyright information

© The Author(s) 2014

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, and provide a link to the Creative Commons license. You do not have permission under this license to share adapted material derived from this article or parts of it.

The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this license, visit (https://doi.org/creativecommons.org/licenses/by-nc-nd/4.0/)

Authors and Affiliations

  • Bixi Jian
    • 1
  • Shaolong Yang
    • 1
  • Irshad H. Chaudry
    • 1
  • Raghavan Raju
    • 1
  1. 1.Department of SurgeryUniversity of Alabama at BirminghamBirminghamUSA

Personalised recommendations